"Comprehensive Cancer Centers, an affiliate of The US Oncology Network, is an award-winning multispecialty practice comprising medical oncology, hematology, radiation oncology, breast surgery, pulmonary medicine, cancer genetic counseling and clinical research."

During the past decade, Comprehensive Cancer Centers of Nevada-Southeast Henderson conducted 123 clinical trials. In the 10-year time frame, 123 clinical trials started and 59 clinical trials were completed, i.e. on average, 48% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 49 clinical trials were completed. i.e. 119.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Comprehensive Cancer Centers of Nevada-Southeast Henderson" #1 sponsor was "National Cancer Institute (NCI)" with 76 trials, followed by "SWOG Cancer Research Network" with 35 trials sponsored, "Alliance for Clinical Trials in Oncology" with 26 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "NRG Oncology" with 12 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Comprehensive Cancer Centers of Nevada-Southeast Henderson" #1 collaborator was "National Cancer Institute (NCI)" with 81 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Comprehensive Cancer Centers of Nevada-Southeast Henderson" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Invasive Breast Carcinoma" (6 trials), "Recurrent Lung Non-Small Cell Carcinoma" (6 trials) and "Stage IV Cutaneous Melanoma AJCC v6 and v7" (6 trials). Many other conditions were trialed in "Comprehensive Cancer Centers of Nevada-Southeast Henderson" in a lesser frequency.

Most popular intervention types in "Comprehensive Cancer Centers of Nevada-Southeast Henderson" are "Drug" (126 trials), "Other" (105 trials), "Biological" (67 trials), "Procedure" (41 trials) and "Radiation" (18 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (51 trials), "Quality-of-Life Assessment" (40 trials), "Computed Tomography" (25 trials), "Biospecimen Collection" (24 trials) and "Nivolumab" (21 trials). Other intervention names were less common.

The vast majority of trials in "Comprehensive Cancer Centers of Nevada-Southeast Henderson" are 138 trials for "All" genders, 18 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Comprehensive Cancer Centers of Nevada-Southeast Henderson". undefined are not yet recruiting, 42 are recruiting, 79 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Comprehensive Cancer Centers of Nevada-Southeast Henderson, 4 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Comprehensive Cancer Centers of Nevada-Southeast Henderson, 3 "Phase 1" clinical trials were conducted, 81 "Phase 2" clinical trials and 79 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".